BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30191738)

  • 21. New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors.
    Filimonov AS; Chepanova AA; Luzina OA; Zakharenko AL; Zakharova OD; Ilina ES; Dyrkheeva NS; Kuprushkin MS; Kolotaev AV; Khachatryan DS; Patel J; Leung IKH; Chand R; Ayine-Tora DM; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31619021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.
    Sirivolu VR; Vernekar SK; Marchand C; Naumova A; Chergui A; Renaud A; Stephen AG; Chen F; Sham YY; Pommier Y; Wang Z
    J Med Chem; 2012 Oct; 55(20):8671-84. PubMed ID: 23006064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Deoxycholic Acid Derived Tyrosyl-DNA Phosphodiesterase 1 Inhibitors Also Inhibit Tyrosyl-DNA Phosphodiesterase 2.
    Salomatina OV; Dyrkheeva NS; Popadyuk II; Zakharenko AL; Ilina ES; Komarova NI; Reynisson J; Salakhutdinov NF; Lavrik OI; Volcho KP
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Products and Their Derivatives as Inhibitors of the DNA Repair Enzyme Tyrosyl-DNA Phosphodiesterase 1.
    Zakharenko AL; Luzina OA; Chepanova AA; Dyrkheeva NS; Salakhutdinov NF; Lavrik OI
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
    Dexheimer TS; Gediya LK; Stephen AG; Weidlich I; Antony S; Marchand C; Interthal H; Nicklaus M; Fisher RJ; Njar VC; Pommier Y
    J Med Chem; 2009 Nov; 52(22):7122-31. PubMed ID: 19883083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma].
    Dyrkheeva NS; Zakharenko AL; Novoselova ES; Chepanova AA; Popova NA; Nikolin VP; Luzina OA; Salakhutdinov NF; Ryabchikova EI; Lavrik OI
    Mol Biol (Mosk); 2021; 55(2):312-317. PubMed ID: 33871444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of the Antitumor and Antimetastatic Effect of Topotecan and Normalization of Blood Counts in Mice with Lewis Carcinoma by Tdp1 Inhibitors-New Usnic Acid Derivatives.
    Kornienko TE; Chepanova AA; Zakharenko AL; Filimonov AS; Luzina OA; Dyrkheeva NS; Nikolin VP; Popova NA; Salakhutdinov NF; Lavrik OI
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Tyrosyl-DNA Phosphodiesterase 1 by Lipophilic Pyrimidine Nucleosides.
    Zakharenko AL; Drenichev MS; Dyrkheeva NS; Ivanov GA; Oslovsky VE; Ilina ES; Chernyshova IA; Lavrik OI; Mikhailov SN
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32823658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2
    Li-Zhulanov NS; Zakharenko AL; Chepanova AA; Patel J; Zafar A; Volcho KP; Salakhutdinov NF; Reynisson J; Leung IKH; Lavrik OI
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30261631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments.
    Mozhaitsev ES; Zakharenko AL; Suslov EV; Korchagina DV; Zakharova OD; Vasil'eva IA; Chepanova AA; Black E; Patel J; Chand R; Reynisson J; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI
    Anticancer Agents Med Chem; 2019; 19(4):463-472. PubMed ID: 30523770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1.
    Dyrkheeva NS; Filimonov AS; Luzina OA; Orlova KA; Chernyshova IA; Kornienko TE; Malakhova AA; Medvedev SP; Zakharenko AL; Ilina ES; Anarbaev RO; Naumenko KN; Klabenkova KV; Burakova EA; Stetsenko DA; Zakian SM; Salakhutdinov NF; Lavrik OI
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual DNA topoisomerase 1 and tyrosyl-DNA phosphodiesterase 1 inhibition for improved anticancer activity.
    Zakharenko A; Dyrkheeva N; Lavrik O
    Med Res Rev; 2019 Jul; 39(4):1427-1441. PubMed ID: 31004352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.
    Dexheimer TS; Antony S; Marchand C; Pommier Y
    Anticancer Agents Med Chem; 2008 May; 8(4):381-9. PubMed ID: 18473723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.
    Nguyen TX; Morrell A; Conda-Sheridan M; Marchand C; Agama K; Bermingham A; Bermingam A; Stephen AG; Chergui A; Naumova A; Fisher R; O'Keefe BR; Pommier Y; Cushman M
    J Med Chem; 2012 May; 55(9):4457-78. PubMed ID: 22536944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Tyrosyl-DNA Phosphodiesterase 1 Inhibitor on the Proapoptotic and Genotoxic Effects of Anticancer Agent Topotecan.
    Chepanova AA; Zakharenko AL; Dyrkheeva NS; Chernyshova IA; Zakharova OD; Ilina ES; Luzina OA; Salakhutdinov NF; Lavrik OI
    Dokl Biochem Biophys; 2023 Feb; 508(1):25-30. PubMed ID: 36653585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.
    Nguyen TX; Abdelmalak M; Marchand C; Agama K; Pommier Y; Cushman M
    J Med Chem; 2015 Apr; 58(7):3188-208. PubMed ID: 25811317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors.
    Huang SN; Pommier Y; Marchand C
    Expert Opin Ther Pat; 2011 Sep; 21(9):1285-92. PubMed ID: 21843105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.
    Lv PC; Agama K; Marchand C; Pommier Y; Cushman M
    J Med Chem; 2014 May; 57(10):4324-36. PubMed ID: 24800942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
    Salomatina OV; Popadyuk II; Zakharenko AL; Zakharova OD; Fadeev DS; Komarova NI; Reynisson J; Arabshahi HJ; Chand R; Volcho KP; Salakhutdinov NF; Lavrik OI
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29562592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Dual Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 and 2 Based on Deoxycholic Acid: Design, Synthesis, Cytotoxicity, and Molecular Modeling.
    Salomatina OV; Kornienko TE; Zakharenko AL; Komarova NI; Achara C; Reynisson J; Salakhutdinov NF; Lavrik OI; Volcho KP
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.